AITbiotech’s Participation In MEDLAB Dubai 2017

Updated: Jun 23

Singapore, Dec 16, 2017 AITbiotech Pte Ltd, the Singapore based genomic service and Molecular Diagnostics (MDx) company, is pleased to announce its first participation in MEDLAB, the world’s largest laboratory exhibition and congress in the middle east, to be held from Feb 6-9, 2017 at the Dubai International Convention & Exhibition Centre, UAE.


The MEDLAB exhibition is an ideal platform for industry players to meet and develop business contacts with the medical and scientific community in the Middle East and from many other countries around the world. With over 600 exhibitors from over 30 countries, the MEDLAB exhibition aim to attract 30, 000 visitors from across the world in 2017. AITbiotech will use this opportunity to exhibit its comprehensive range of abTES™ Molecular Diagnostics (MDx) assays, including the newly launched Zika assays and the multiplex respiratory panel.


According to Alex Thian, CEO of AITbiotech; “We are excited to be part of this premier exhibition. After many years of development of our assays and focusing in the Asia Pacific market, we are finally are able to expand to more markets. We believe that Middle East will be the best market for us to expand into, primarily due to the relevance of our abTES™ assay offerings to the needs of the Middle East Market. We are looking for local partners to work with us collaboratively to introduce our abTES™ MDx assays to the Middle East market.”


Media Contacts



0 views0 comments

Recent Posts

See All

COVID-19 Test; AITbiotech A Singapore Based Molecular Diagnostic Company launches a Fast and Simple-to-use RNA-based test for COVID-19 using LAMP technologies As COVID-19 overwhelms health care resour